ITMI920608A1 - Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare - Google Patents

Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare

Info

Publication number
ITMI920608A1
ITMI920608A1 IT000608A ITMI920608A ITMI920608A1 IT MI920608 A1 ITMI920608 A1 IT MI920608A1 IT 000608 A IT000608 A IT 000608A IT MI920608 A ITMI920608 A IT MI920608A IT MI920608 A1 ITMI920608 A1 IT MI920608A1
Authority
IT
Italy
Prior art keywords
amino
cardiovascular system
derivatives active
tetraline derivatives
tetraline
Prior art date
Application number
IT000608A
Other languages
English (en)
Inventor
Giorgio Bertolini
Cesare Casagrande
Francesco Marchini
Stefania Motanari
Francesco Santangelo
Claudio Semeraro
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of ITMI920608A0 publication Critical patent/ITMI920608A0/it
Priority to ITMI920608A priority Critical patent/IT1254521B/it
Priority to AT93906515T priority patent/ATE137737T1/de
Priority to HU9303266A priority patent/HUT68936A/hu
Priority to JP51622793A priority patent/JP3231775B2/ja
Priority to PL93315380A priority patent/PL172056B1/pl
Priority to ES93906515T priority patent/ES2087729T3/es
Priority to NZ249845A priority patent/NZ249845A/en
Priority to DK93906515.7T priority patent/DK0585440T3/da
Priority to PCT/EP1993/000577 priority patent/WO1993019036A1/en
Priority to KR1019930703509A priority patent/KR100283945B1/ko
Priority to RU93058292A priority patent/RU2120435C1/ru
Priority to EP93906515A priority patent/EP0585440B1/en
Priority to PL93301342A priority patent/PL171844B1/pl
Priority to MD96-0271A priority patent/MD1449G2/ro
Priority to FI935066A priority patent/FI935066L/fi
Priority to AU37478/93A priority patent/AU650201C/en
Priority to DE69302544T priority patent/DE69302544T2/de
Priority to CA002102490A priority patent/CA2102490C/en
Priority to US08/032,845 priority patent/US5407956A/en
Publication of ITMI920608A1 publication Critical patent/ITMI920608A1/it
Priority to OA60433A priority patent/OA09843A/en
Priority to NO934160A priority patent/NO180230C/no
Priority to US08/281,698 priority patent/US5451608A/en
Priority to HU95P/P00509P priority patent/HU211517A9/hu
Application granted granted Critical
Publication of IT1254521B publication Critical patent/IT1254521B/it
Priority to GR960401792T priority patent/GR3020419T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
ITMI920608A 1992-03-17 1992-03-17 Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare IT1254521B (it)

Priority Applications (24)

Application Number Priority Date Filing Date Title
ITMI920608A IT1254521B (it) 1992-03-17 1992-03-17 Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
PL93301342A PL171844B1 (pl) 1992-03-17 1993-03-13 P ochodne 2-amino-1,2,3,4-tetrahydronaftalenu PL PL PL
FI935066A FI935066L (fi) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaftalenderivat aktivt inverkande pao kardiovaskularsystemet, foerfaranden foer framstaellning av dem och farmaceutiska kompositioner innehaollande dem
JP51622793A JP3231775B2 (ja) 1992-03-17 1993-03-13 心循環器系に作用する２−アミノ−１，２，３，４−テトラヒドロナフタレン誘導体、それらを製造する方法、及びそれらを含む医薬組成物
PL93315380A PL172056B1 (pl) 1992-03-17 1993-03-13 Sposób wytwarzania pochodnych 2-amino-1,2,3,4-tetrahydronaftalenu PL
ES93906515T ES2087729T3 (es) 1992-03-17 1993-03-13 Derivados de 2-amino-1,2,3,4-tetrahidronaftaleno activos sobre el sistema cardiovascular, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
NZ249845A NZ249845A (en) 1992-03-17 1993-03-13 2-aminotetralin derivatives, medicaments
DK93906515.7T DK0585440T3 (da) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaphtalen-derivater med virkning på det cardiovasculære system fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
PCT/EP1993/000577 WO1993019036A1 (en) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
KR1019930703509A KR100283945B1 (ko) 1992-03-17 1993-03-13 심장 혈관계에 활성인 2-아미노-1,2,3,4-테트라히드로나프탈렌유도체, 이들의 제조방법 및 이들을 함유하는 약제 조성물
RU93058292A RU2120435C1 (ru) 1992-03-17 1993-03-13 Производные 2-амино-1,2,3,4-тетрагидронафталина или их фармацевтически приемлемые соли и композиция, обладающая кардиоваскулярной активностью
EP93906515A EP0585440B1 (en) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
AT93906515T ATE137737T1 (de) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaphthalen derivate mit wirkung auf das kardiovasculäre system, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen
MD96-0271A MD1449G2 (ro) 1992-03-17 1993-03-13 Derivaţi ai 2-amino-1,2,3,4-tetrahidronaftalinei cu acţiune asupra sistemului cardiovascular, procedeu de obţinere a acestora şi compoziţii farmaceutice care îi conţin
HU9303266A HUT68936A (en) 1992-03-17 1993-03-13 Process for preparing 2-amino-1,2,3,4-tetrahydronaphtalene derivatives and pharmaceutical compositions containing them
AU37478/93A AU650201C (en) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
DE69302544T DE69302544T2 (de) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaphthalen derivate mit wirkung auf das kardiovasculäre system, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen
CA002102490A CA2102490C (en) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
US08/032,845 US5407956A (en) 1992-03-17 1993-03-17 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
OA60433A OA09843A (en) 1992-03-17 1993-11-11 2-Amino-1, 2, 3, 4-tetahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
NO934160A NO180230C (no) 1992-03-17 1993-11-17 2-amino-1,2,3,4-tetrahydronaftalenderivater med kardiovaskulær aktivitet samt farmasöytiske preparater inneholdende slike
US08/281,698 US5451608A (en) 1992-03-17 1994-07-28 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovasular system, processes for their preparation and pharmaceutical compositions containing them
HU95P/P00509P HU211517A9 (en) 1992-03-17 1995-06-28 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
GR960401792T GR3020419T3 (en) 1992-03-17 1996-07-02 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920608A IT1254521B (it) 1992-03-17 1992-03-17 Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare

Publications (3)

Publication Number Publication Date
ITMI920608A0 ITMI920608A0 (it) 1992-03-17
ITMI920608A1 true ITMI920608A1 (it) 1993-09-17
IT1254521B IT1254521B (it) 1995-09-25

Family

ID=11362451

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920608A IT1254521B (it) 1992-03-17 1992-03-17 Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare

Country Status (20)

Country Link
US (2) US5407956A (it)
EP (1) EP0585440B1 (it)
JP (1) JP3231775B2 (it)
KR (1) KR100283945B1 (it)
AT (1) ATE137737T1 (it)
CA (1) CA2102490C (it)
DE (1) DE69302544T2 (it)
DK (1) DK0585440T3 (it)
ES (1) ES2087729T3 (it)
FI (1) FI935066L (it)
GR (1) GR3020419T3 (it)
HU (2) HUT68936A (it)
IT (1) IT1254521B (it)
MD (1) MD1449G2 (it)
NO (1) NO180230C (it)
NZ (1) NZ249845A (it)
OA (1) OA09843A (it)
PL (2) PL171844B1 (it)
RU (1) RU2120435C1 (it)
WO (1) WO1993019036A1 (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271411B (it) * 1993-09-14 1997-05-28 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare
IT1274673B (it) * 1994-04-14 1997-07-24 Zambon Spa Derivati dell'acido fosfonico utili nel trattamento delle malattie car.iovascolari
IT1270260B (it) * 1994-06-21 1997-04-29 Zambon Spa Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
IT1271008B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare
IT1271009B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del benzopirano e del benzotiopirano attivi sul sistema cardiovascolare
IT1271007B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidronaftalene attivi sul sistema cardiovascolare
IT1273455B (it) * 1995-01-27 1997-07-08 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
IT1276710B1 (it) * 1995-06-14 1997-11-03 Zambon Spa Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi
GB9625455D0 (en) * 1996-12-07 1997-01-22 Glaxo Group Ltd Process for resolving mixtures of carbocyclic steroisomers
IT1289980B1 (it) * 1997-02-26 1998-10-19 Zambon Spa Derivati idrossimetilici del 2-ammino-1,2,3,4-tetraidronaftalene attivi in campo cardiovascolare
MX2011005979A (es) * 2008-12-09 2011-06-27 Interquim Sa Procedimiento de obtencion de (6s)-(-)-5,6,7,8-tetrahidro-6-[propi l-(2-tienil)etil]amino-1-naftol(rotigotina).

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072061B1 (en) * 1981-08-05 1985-05-15 FISONS plc Amine derivatives, processes for their production and pharmaceutical compositions containing them
EP0142283B1 (en) * 1983-10-25 1991-01-30 FISONS plc Phenylethylamines, process for their preparation and compositions containing them
IT1224405B (it) * 1987-12-23 1990-10-04 Simes Composti attivi sul sistema cardiovascolare

Also Published As

Publication number Publication date
MD1449G2 (ro) 2000-12-31
JP3231775B2 (ja) 2001-11-26
NO934160L (no) 1993-11-17
KR100283945B1 (ko) 2001-03-02
AU3747893A (en) 1993-10-21
HU211517A9 (en) 1995-11-28
DE69302544D1 (de) 1996-06-13
CA2102490C (en) 2004-06-08
EP0585440B1 (en) 1996-05-08
RU2120435C1 (ru) 1998-10-20
IT1254521B (it) 1995-09-25
WO1993019036A1 (en) 1993-09-30
MD1449F1 (en) 2000-04-30
JPH06507920A (ja) 1994-09-08
EP0585440A1 (en) 1994-03-09
US5407956A (en) 1995-04-18
DE69302544T2 (de) 1996-09-19
ATE137737T1 (de) 1996-05-15
HUT68936A (en) 1995-08-28
US5451608A (en) 1995-09-19
OA09843A (en) 1994-08-15
DK0585440T3 (da) 1996-06-10
NO180230B (no) 1996-12-02
ITMI920608A0 (it) 1992-03-17
NZ249845A (en) 1996-03-26
PL171844B1 (pl) 1997-06-30
MD960271A (en) 1997-09-30
PL172056B1 (pl) 1997-07-31
GR3020419T3 (en) 1996-10-31
NO180230C (no) 1997-03-12
AU650201B2 (en) 1994-06-09
NO934160D0 (no) 1993-11-17
ES2087729T3 (es) 1996-07-16
FI935066A7 (fi) 1993-11-16
CA2102490A1 (en) 1993-09-18
FI935066A0 (fi) 1993-11-16
FI935066L (fi) 1993-11-16

Similar Documents

Publication Publication Date Title
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DE59006506D1 (de) Transdermale Applikation von 2-Amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol.
AU618443B2 (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
ITMI920608A1 (it) Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
ES2168384T3 (es) Derivados de 2-amino-1,2,3,4-tetrahidronaftaleno activos para el sistema cardiovascular.
ITMI931973A0 (it) Derivati del 2-ammino-1,2,3,4-tetraudro-naftalene attivi sul sistema cardiovascolare
NO893909D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
ES2124765T3 (es) N-acil derivados de hidroxiaminas que tienen actividad eliminadora y que son utiles en patologias agudas y cronicas asociadas con los fenomenos de peroxidacion e inflamacion.
ES2191206T3 (es) Nueva utilizacion de la creatina.
IT1243846B (it) Derivato della melatonina ad attivita' terapeutica in dermatologia.
DK631989A (da) Anti-plakmiddel og/eller middel til behandling af lidelser i mundhulen
ES2087764T3 (es) Uso del ajo de oso en el tratamiento o prevencion de los trastornos circulatorios.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
ATE100332T1 (de) Pharmazeutische zusammensetzung, verwendbar bei der behandlung von herzgefaesserkrankungen.
DK160821C (da) 1,3-dihydro-4-benzoyl-2h-imidazol-2-oner samt middel til behandling af hjertesvigt
DK31889A (da) Anvendelse af cyclophilin som antiinflammatorisk og immunmodulerende middel.
SE8802040D0 (sv) New use
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
IT1241456B (it) Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516)
FI950951A7 (fi) Farmaseuttisia aineita veren uudelleenvirtauksesta sydämen läpi aiheutuneen sydänlihasvaurion ja sydänpysähdyksen hoitamiseksi
IT8321358A0 (it) Derivati ad attivita' terapeutica della s-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ATE72813T1 (de) 1,5-benzothiazepinderivate, ihre herstellung und ihre verwendung in der behandlung von kardiovasculaeren stoerungen.
ATE103814T1 (de) Pharmazeutische zusammensetzungen und deren verwendung in der behandlung von entzuendungen.
IT8309569A0 (it) Applicazione terapeutica di farmaci ad attivita' antiproteolitica speci ficanel trattamento delle ulcere torpide